Acute hyperhomocysteinemia decreases NO bioavailability in healthy adults

Hyperhomocysteinemia is associated with decreased vascular reactivity and increased cardiovascular morbidity. Oxidative stress and reduced NO bioavailability have been proposed as a mechanism for the adverse effects of chronically elevated plasma homocysteine levels. Recent studies suggest that acut...

Full description

Saved in:
Bibliographic Details
Main Authors: Romerio, Silvana C. (Author) , Linder-Schönenberger, Lilly (Author) , Nyfeler, Jürg (Author) , Wenk, Markus (Author) , Litynsky, Piotr (Author) , Asmis, Reto (Author) , Haefeli, Walter E. (Author)
Format: Article (Journal)
Language:English
Published: 28 July 2004
In: Atherosclerosis
Year: 2004, Volume: 176, Issue: 2, Pages: 337-344
ISSN:1879-1484
DOI:10.1016/j.atherosclerosis.2004.05.014
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.atherosclerosis.2004.05.014
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0021915004002825
Get full text
Author Notes:Silvana C. Romerio, Lilly Linder, Jürg Nyfeler, Markus Wenk, Piotr Litynsky, Reto Asmis, Walter E. Haefeli
Description
Summary:Hyperhomocysteinemia is associated with decreased vascular reactivity and increased cardiovascular morbidity. Oxidative stress and reduced NO bioavailability have been proposed as a mechanism for the adverse effects of chronically elevated plasma homocysteine levels. Recent studies suggest that acute elevations of plasma homocysteine may also impair endothelial function and vasodilation, however, the mechanism is not clear. In the present study, we investigated whether moderate hyperhomocysteinemia after methionine loading decreases NO bioavailability, increases oxidative stress, and impairs receptor-mediated NO-dependent venodilation in healthy adults. After oral methionine loading (0.1g/kg), mean homocysteine concentrations increased 3.2-fold, from 6.9 ± 0.5 to 27.8 ± 1.9μmol/l (n = 16), whereas plasma NOx concentrations, an indicator of NO release, were decreased by 12% compared to placebo treatment (P = 0.005). Vitamin E levels in freshly isolated low density lipoprotein (LDL), a sensitive marker of LDL oxidation, and LDL lipid (hydro)peroxide levels were unchanged after methionine loading. Endothelium-dependent venodilation induced by bradykinin was reduced by 18% during hyperhomocysteinemia (P = 0.06). Taken together our data suggest that the reduced NO bioavailability was likely due to decreased NO synthesis and release rather than to NO destruction by oxidative stress.
Item Description:Gesehen am 19.05.2021
Physical Description:Online Resource
ISSN:1879-1484
DOI:10.1016/j.atherosclerosis.2004.05.014